463 related articles for article (PubMed ID: 15877793)
21. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
22. Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
Choquet S; Oertel S; LeBlond V; Riess H; Varoqueaux N; Dörken B; Trappe R
Ann Hematol; 2007 Aug; 86(8):599-607. PubMed ID: 17522862
[TBL] [Abstract][Full Text] [Related]
23. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B
J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742
[TBL] [Abstract][Full Text] [Related]
24. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
Knoop C; Kentos A; Remmelink M; Garbar C; Goldman S; Feremans W; Estenne M
Clin Transplant; 2006; 20(2):179-87. PubMed ID: 16640524
[TBL] [Abstract][Full Text] [Related]
25. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ
J Heart Lung Transplant; 2015 Nov; 34(11):1406-14. PubMed ID: 26279197
[TBL] [Abstract][Full Text] [Related]
26. Ultra-early onset post-transplantation lymphoproliferative disease.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1144-52. PubMed ID: 24231475
[TBL] [Abstract][Full Text] [Related]
27. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
Dharnidharka VR; Stevens G
Pediatr Transplant; 2005 Oct; 9(5):622-6. PubMed ID: 16176420
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
Elidemir O; Kancherla BS; Schecter MG; McKenzie ED; Morales DL; Heinle JS; Mallory GB
Pediatr Transplant; 2009 Aug; 13(5):606-10. PubMed ID: 19017289
[TBL] [Abstract][Full Text] [Related]
29. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(3):74-7. PubMed ID: 19644164
[TBL] [Abstract][Full Text] [Related]
30. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
31. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
32. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival after post-transplant lymphoproliferative disease in children.
Nathanson S; Debray D; Delarue A; Deschênes G
Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
[TBL] [Abstract][Full Text] [Related]
34. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
Fernández MC; Bes D; De Dávila M; López S; Cambaceres C; Dip M; Imventarza O
Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
[TBL] [Abstract][Full Text] [Related]
35. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
36. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
37. Incidence and consequences of post-transplantation lymphoproliferative disorders.
Boubenider S; Hiesse C; Goupy C; Kriaa F; Marchand S; Charpentier B
J Nephrol; 1997; 10(3):136-45. PubMed ID: 9238621
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
40. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
